Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor-null mice with diet-induced insulin resistance - Wikidata - wikimedia - TriplyDB

Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor-null mice with diet-induced insulin resistance

Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor-null mice with diet-induced insulin resistance

http://www.wikidata.org/entity/Q24648189

about

Antidiabetic properties of dietary flavonoids: a cellular mechanism review Phytochemicals as novel agents for the induction of browning in white adipose tissue A Review of Natural Stimulant and Non-stimulant Thermogenic Agents The absence of MIST1 leads to increased ethanol sensitivity and decreased activity of the unfolded protein response in mouse pancreatic acinar cells Antiobesity Effects of an Edible Halophyte Nitraria retusa Forssk in 3T3-L1 Preadipocyte Differentiation and in C57B6J/L Mice Fed a High Fat Diet-Induced Obesity.PPARδ activation attenuates hepatic steatosis in Ldlr-/- mice by enhanced fat oxidation, reduced lipogenesis, and improved insulin sensitivity Effect of citrus flavonoids, naringin and naringenin, on metabolic syndrome and their mechanisms of action.Apolipoprotein B100 quality control and the regulation of hepatic very low density lipoprotein secretion.Enhancement of naringenin bioavailability by complexation with hydroxypropyl-β-cyclodextrin. [corrected]Sudachitin, a polymethoxylated flavone, improves glucose and lipid metabolism by increasing mitochondrial biogenesis in skeletal muscle.Transcriptional regulation of human and rat hepatic lipid metabolism by the grapefruit flavonoid naringenin: role of PPARalpha, PPARgamma and LXRalpha.Niemann-Pick C1-Like 1 deletion in mice prevents high-fat diet-induced fatty liver by reducing lipogenesis.Positive outcomes of oil palm phenolics on degenerative diseases in animal models GLP-1 receptor activation inhibits VLDL production and reverses hepatic steatosis by decreasing hepatic lipogenesis in high-fat-fed APOE*3-Leiden mice Citrus flavonoids repress the mRNA for stearoyl-CoA desaturase, a key enzyme in lipid synthesis and obesity control, in rat primary hepatocytes Effects of p-synephrine alone and in combination with selected bioflavonoids on resting metabolism, blood pressure, heart rate and self-reported mood changes.Effects of Fortunella margarita fruit extract on metabolic disorders in high-fat diet-induced obese C57BL/6 mice The flavonoid, naringenin, decreases adipose tissue mass and attenuates ovariectomy-associated metabolic disturbances in mice.Naringenin inhibits the assembly and long-term production of infectious hepatitis C virus particles through a PPAR-mediated mechanism.Naringenin ameliorates pathological changes in liver and kidney of diabetic mice: a preliminary study.Protection from Metabolic Dysregulation, Obesity, and Atherosclerosis by Citrus Flavonoids: Activation of Hepatic PGC1α-Mediated Fatty Acid Oxidation.A naturally occurring naringenin derivative exerts potent bone anabolic effects by mimicking oestrogen action on osteoblasts Effect of the peels of two Citrus fruits on endothelium function in adolescents with excess weight: A triple-masked randomized trial PGC-1α overexpression results in increased hepatic fatty acid oxidation with reduced triacylglycerol accumulation and secretion.Association between dietary flavanones intake and lipid profiles according to the presence of metabolic syndrome in Korean women with type 2 diabetes mellitus.Citrus flavonoid, naringenin, increases locomotor activity and reduces diacylglycerol accumulation in skeletal muscle of obese ovariectomized mice.Naringenin prevents cholesterol-induced systemic inflammation, metabolic dysregulation, and atherosclerosis in Ldlr⁻/⁻ mice.Naringenin Ameliorated Kidney Injury through Let-7a/TGFBR1 Signaling in Diabetic Nephropathy.Naringenin inhibits adipogenesis and reduces insulin sensitivity and adiponectin expression in adipocytes.Protective effect of naringenin on acetic acid-induced ulcerative colitis in rats.Flavonoids as dietary regulators of nuclear receptor activity The effect of Citrus Aurantifolia (Lemon) peels on cardiometabolic risk factors and markers of endothelial function in adolescents with excess weight: A triple-masked randomized controlled trial.Flavonoids and metabolic syndrome.A new perspective on the quercetin paradox in male reproductive dysfunction.Chemoprevention of nonalcoholic fatty liver disease by dietary natural compounds.A review on pharmacological and analytical aspects of naringenin.100% citrus juice: Nutritional contribution, dietary benefits, and association with anthropometric measures.The potential of flavonoids in the treatment of non-alcoholic fatty liver disease.Characterization of mango (Mangifera indica L.) transcriptome and chloroplast genome.Natural antioxidants for non-alcoholic fatty liver disease: molecular targets and clinical perspectives.

P2860

Q26771961-CD340C78-1B62-4C69-8D88-759BB8FF2B75 Q28073857-C0CF4E9F-9F8F-4FA3-8865-C418CB82A07F Q28076560-58EEA876-2662-45D5-973A-B2365E326BEA Q28478610-28A28978-2892-4138-B2D0-0C77BE0DD888 Q30392630-3D4F39F8-656F-485E-AAEC-269438E28624 Q33825128-4CE5C2A2-ECFF-4F02-B263-06CF9F84B013 Q33857214-A7944D3B-E52D-4197-8D97-18BA618A45D2 Q33858526-D17862D5-7AA9-4217-839D-C9316BE1BF69 Q33873730-50D56D74-2903-46B3-9764-9F18E72199AA Q34041717-8AA6556B-8C6F-4C99-A88E-17FD679564CE Q34084372-751347BC-C709-47DC-852E-CD748A5ADD7B Q34187966-9A220FD8-AE7C-40D0-B3B5-71C3DC22F949 Q34264552-5E3253E5-D7EB-433F-9DAA-685E620C395F Q34469947-065C6418-A975-4B70-9D18-73F3AFC48610 Q34668864-8309EB1A-7FF9-4D70-AE3A-6C58EC9BEBD4 Q34893795-F3653B27-231B-49CD-AF5D-314AFF51D7F6 Q35140214-B91FCD4F-828E-49AC-B8C3-EA7B4FA57035 Q35149393-B3B82738-5FC5-42E8-A2C2-6DAA756326D1 Q35399890-CFFDA1AB-A8C1-4F4F-81C4-9DD8063B92BA Q35993515-B42F2163-5FC2-48E3-BC16-85B4D75FF500 Q36014621-E306644D-0BAA-4B2E-9C0A-3F33C3EA5767 Q36024969-7641E472-2C43-46C2-A024-CEE144E9F553 Q36298278-D57E7DBC-8505-4F30-B777-DCD441BF1FAC Q36312713-51C3A0A4-5BDF-4439-BD3B-4E70FB26F1FF Q36547075-C38ED604-6A1A-499D-8FB7-3EE21FA6C2B4 Q36679809-5830FD39-8DE5-4DA1-9D63-4D04302C2DB3 Q36744105-E0A62BDA-FB29-412C-A5B2-0CBAA05DD723 Q37092968-703E5381-BC55-41DF-A660-844FCF83CEBA Q37101078-B862E645-30DB-4909-A0F8-A02083B42CD5 Q37162436-27FD0C66-5DE4-43B7-862E-4C2BF6FA3F8A Q37193003-C9B6223B-7E3A-46C3-9042-6AE51E2EE66A Q37640437-49663B7E-4E57-4653-8FC3-E6B94A9F3C4C Q38023567-F25B97BF-E554-471F-9984-9C4E2BD0A55E Q38034198-7B8E672C-07F1-4DC9-BA05-B69660C548B4 Q38168505-D682A8D5-E5D9-41CF-8B10-DAE441B67CE7 Q38287028-ADBD009A-537C-4186-A862-04F514C98901 Q38399700-DAC72E4B-FB72-44B3-998D-63D2DBC8CA5B Q38432731-0B064531-6902-4096-A18E-2C0B8DEFC45B Q38479921-6548344D-EEF9-41F4-8601-BEC8F981DFC7 Q38599131-B4C332FF-DE92-4DF8-B8D9-C95BA14F270C

P2860

Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor-null mice with diet-induced insulin resistance

http://www.wikidata.org/entity/Q24648189

description

2009 nî lūn-bûn

@nan

2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Naringenin prevents dyslipidem ...... iet-induced insulin resistance

@ast

Naringenin prevents dyslipidem ...... iet-induced insulin resistance

@en

Naringenin prevents dyslipidem ...... iet-induced insulin resistance

@nl

type

label

Naringenin prevents dyslipidem ...... iet-induced insulin resistance

@ast

Naringenin prevents dyslipidem ...... iet-induced insulin resistance

@en

Naringenin prevents dyslipidem ...... iet-induced insulin resistance

@nl

prefLabel

Naringenin prevents dyslipidem ...... iet-induced insulin resistance

@ast

Naringenin prevents dyslipidem ...... iet-induced insulin resistance

@en

Naringenin prevents dyslipidem ...... iet-induced insulin resistance

@nl

P1433

Q24648189-EF9C6878-02A7-417C-BDA1-4274555DC312

P1476

Q24648189-46BF2FAA-F6FA-4E10-B98C-558F5355DAF0

P2093

Q24648189-17744F24-C4A4-4E28-BB21-C9C312974FAC

Q24648189-24AB9948-AACD-4A73-A2FA-8269C7D0730B

Q24648189-261E97D4-7FB8-4FF3-907B-E1B3C3159F7C

Q24648189-2FBC8A1A-AFEE-42C4-8A5E-631821E66235

Q24648189-6F645D68-3C53-48C0-9E68-AE3051985F5C

Q24648189-7850377E-8318-428C-AFBB-D51F182E7FCE

Q24648189-998ADA1C-9E9F-43A4-BBB3-7830D1450FBB

Q24648189-FD0DD0CA-3690-4F1B-8292-14E78932F2BB

P2860

Q24648189-02371E57-4BD8-4040-90C0-E03C5E7B2041

Q24648189-078073E7-94AE-452E-91A5-580C6C8AA2A1

Q24648189-0CB9F4D4-F850-4B5B-8805-CCBFF5C74806

Q24648189-0E69E8AA-CFD3-408A-84A2-4E3661D530ED

Q24648189-101D518F-7FCB-4654-A0F3-A201F5E77BCD

Q24648189-1370D73E-ABDA-45B3-9D43-1B14D28D2BAC

Q24648189-18CFCE11-CE4B-40BC-9739-8E7A65B90B0E

Q24648189-1ED62CC1-2FDC-46CE-A07B-F85978E2234D

Q24648189-1FF570CC-D319-46C1-AA03-3270450D2445

Q24648189-298AB416-DCDA-4E07-8764-BD6515C887D2

P304

Q24648189-9DAC387D-CA13-4DF3-9911-6647071EDDEE

P31

Q24648189-77280511-96E9-4744-9CF7-349D4A0AAC15

P3181

Q24648189-30171BEE-9909-480F-83AD-AFC77F6A1964

P356

Q24648189-C4EB5E1E-455F-434D-BCFB-3B5936C8CDBE

P407

Q24648189-4DABA975-1042-45B7-910D-11C71B503A27

P433

Q24648189-94AF4FF0-32CB-4A6F-AD89-50F1116D113D

P478

Q24648189-DE9289FC-739C-4717-B6F6-A63E7F21C7ED

P50

Q24648189-FE81AD79-9DCF-40B9-BE59-1C648205AD38

P577

Q24648189-D8F39FCB-CB22-4A1F-9750-1461FD9E2CA4

P5875

Q24648189-775CB1D0-5C0F-46CA-8741-6416CEB675AD

P698

Q24648189-CFC7B0A5-D387-406C-B966-2D64CC8D3638

P921

Q24648189-027A6A6B-1D92-4724-9107-4B5909EE395D

Q24648189-F6D1BD7F-ACC0-4E2D-B33C-73AAA8694EDC

P932

Q24648189-87AF5DE0-F390-4CA7-823F-71FD8EF8E1F7

P3181

P356

P1433

P1476

Naringenin prevents dyslipidem ...... iet-induced insulin resistance

@en

P2093

Brian G Sutherland

http://www.w3.org/2001/XMLSchema#string

Cynthia G Sawyez

http://www.w3.org/2001/XMLSchema#string

Dawn E Telford

http://www.w3.org/2001/XMLSchema#string

Emma M Allister

http://www.w3.org/2001/XMLSchema#string

Erin E Mulvihill

http://www.w3.org/2001/XMLSchema#string

Jane Y Edwards

http://www.w3.org/2001/XMLSchema#string

Janet M Markle

http://www.w3.org/2001/XMLSchema#string

Murray W Huff

http://www.w3.org/2001/XMLSchema#string

P2860

PGC-1alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis

Resveratrol improves health and survival of mice on a high-calorie diet

Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice

Positive regulation of the peroxisomal beta-oxidation pathway by fatty acids through activation of peroxisome proliferator-activated receptors (PPAR)

Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha

A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels

The metabolic syndrome

Metabolic control through the PGC-1 family of transcription coactivators

Acyl coenzyme A: cholesterol acyltransferase inhibition and hepatic apolipoprotein B secretion.

Cholesterol-lowering activity of naringenin via inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase and acyl coenzyme A:cholesterol acyltransferase in rats.

P304

2198-210

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

376988

http://www.w3.org/2001/XMLSchema#string

P356

10.2337/DB09-0634

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

58

http://www.w3.org/2001/XMLSchema#string

P50

Robert A. Hegele

P577

2009-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26661561

http://www.w3.org/2001/XMLSchema#string

P698

19592617

http://www.w3.org/2001/XMLSchema#string

P921

P932

2750228

http://www.w3.org/2001/XMLSchema#string